Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture.
about
Pathophysiological role of host microbiota in the development of obesityImmune-microbiota interactions in health and diseaseRegulation of the gut microbiota by the mucosal immune system in mice.The composition of the gut microbiota throughout life, with an emphasis on early life.Gut microbiome composition is associated with temperament during early childhood.Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications.The gut microbiota engages different signaling pathways to induce Duox2 expression in the ileum and colon epithelium.Site-specific programming of the host epithelial transcriptome by the gut microbiotaMicrobiota-mediated inflammation and antimicrobial defense in the intestine.Characterizing the interactions between a naturally primed immunoglobulin A and its conserved Bacteroides thetaiotaomicron species-specific epitope in gnotobiotic mice.Genetic and environmental control of host-gut microbiota interactions.Gut biogeography of the bacterial microbiota.Know your neighbor: Microbiota and host epithelial cells interact locally to control intestinal function and physiology.The A0 blood group genotype modifies the jejunal glycomic binding pattern profile of piglets early associated with a simple or complex microbiota.Chronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice.Core 1- and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in miceDefensins, lectins, mucins, and secretory immunoglobulin A: microbe-binding biomolecules that contribute to mucosal immunity in the human gut.Mucin glycan foraging in the human gut microbiome.The Densely O-Glycosylated MUC2 Mucin Protects the Intestine and Provides Food for the Commensal Bacteria.Host Genome Influence on Gut Microbial Composition and Microbial Prediction of Complex Traits in Pigs.The mucosal barrier at a glance.The resilience of the intestinal microbiota influences health and disease.Microbiota-induced obesity requires farnesoid X receptorMicrobial, metabolomic, and immunologic dynamics in a relapsing genetic mouse model of colitis induced by T-synthase deficiency.The influence of rosuvastatin on the gastrointestinal microbiota and host gene expression profiles.Mouse models for human intestinal microbiota research: a critical evaluation.CD1d-mediated lipid presentation by CD11c+ cells regulates intestinal homeostasis.Engineered Glycocalyx Regulates Stem Cell Proliferation in Murine Crypt Organoids.Intestinal Muc2 mucin O-glycosylation is affected by microbiota and regulated by differential expression of glycosyltranferases.Exposure to the gut microbiota drives distinct methylome and transcriptome changes in intestinal epithelial cells during postnatal development.Parasite-Microbiota Interactions With the Vertebrate Gut: Synthesis Through an Ecological Lens.
P2860
Q26750893-2FC89B40-3687-4A6C-A534-755C770D5E26Q26827944-7A1280C0-C8FF-47AC-9CB3-C83613EE2CE2Q34081385-8930D1DF-0E03-427E-BDD1-482CF8DADD2FQ35044607-A53D0BEA-487F-439C-9785-629107F52B44Q35125886-B7246290-AB8B-4225-8608-07008BAEBD3DQ35209399-BAFCE45A-0C83-4FC9-9729-47CD852BA356Q35232650-22BE065F-5C32-4062-8160-CCB1903A206DQ35500118-A7C3C420-67AA-4177-A9C2-1814AA2690E4Q35541605-1105120D-6626-4909-B180-7FC3564C2E05Q35608094-0D11674B-BABE-4CC2-B420-3D9DDB0DE8C7Q35742093-CC0CFD9D-4862-48E2-B364-91152FEFA115Q35820919-99F2033F-05F1-4963-95F3-E97011794A3BQ35962328-FA262D05-C725-4843-A806-364DEC843DF6Q35985871-C07155AA-27E3-45CD-A1FF-ADA35D1E2987Q37137264-604D691A-7148-4573-AD9E-33EA0BCFA034Q37395969-6F1D3DFB-0B20-42FE-AA44-B9E71B80F804Q37583886-3DD0C919-49DB-4720-ACBA-B1B0B2EBB41CQ38411042-CE001ADA-3E21-43BC-8A80-8D2648E2F4C1Q38734952-B5968DAD-B3E6-4A29-97AD-607A0F8B4DE0Q38806443-8AB96DDE-ABDB-4948-A128-0BA81FE4835CQ39071909-4E2BA5D9-141B-4E88-A850-30CEB13DC7ABQ39308455-FA2E22D2-D6BE-48F1-B704-8B1B02E4EADFQ41172280-BD8FF283-FC26-4215-982C-9D6844D1D930Q43631883-69DBF245-79A6-4156-8B20-FA85C0FAEFADQ46416641-48FC8B11-6074-45B4-A7DB-1BFAFFE0C9AAQ47620267-8F668FB3-49DD-47BC-8D3E-E041BBAB435DQ48148150-E838DE1F-6C70-4017-965F-A9E5FB0CBFDAQ50074949-BAEED44E-9820-4F0B-A1DE-654EB426A409Q51168862-CA68D2A7-4252-4189-A65A-36A0CB46F8F1Q52589510-BA592B0A-EEE3-48B2-AF4B-A44D05A8EC48Q55257312-797852D2-B228-445D-B990-8C870F0A686E
P2860
Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Altered mucus glycosylation in ...... n and intestinal architecture.
@en
Altered mucus glycosylation in ...... n and intestinal architecture.
@nl
type
label
Altered mucus glycosylation in ...... n and intestinal architecture.
@en
Altered mucus glycosylation in ...... n and intestinal architecture.
@nl
prefLabel
Altered mucus glycosylation in ...... n and intestinal architecture.
@en
Altered mucus glycosylation in ...... n and intestinal architecture.
@nl
P2860
P50
P1433
P1476
Altered mucus glycosylation in ...... on and intestinal architecture
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0085254
P407
P577
2014-01-09T00:00:00Z